Innovation
-
Innovation
How do consumer insights fuel our innovation?
By asking our consumers what matters to them, we can keep innovating and evolving our products. Importantly, this is not just about using our science to improve the products themselves – but also how the product is delivered.
-
Innovation
Lupus: the search for a cure continues
Doctors and their patients face an ongoing battle to manage this chronic and sometimes debilitating and life-threatening condition. See how we’re trying to help.
-
Innovation
Getting on target in autoimmune diseases
Our immune system is a complex network of cells in our bodies that work together to protect us from harmful germs.But what happens when these cells malfunction?
-
Innovation
Scientists or detectives? Seeking new clues in COPD
It is now widely accepted that COPD is not a uniform disease, but effects of the disease can impact people differently.
-
Innovation
Take a deep breath – your lung microbiome will appreciate it
Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity
-
Innovation
Cell and gene therapy: a new era of medicine
If we can pinpoint a faulty gene and correct it, could we potentially find a way to cure genetic diseases?
-
Innovation
Cancer gets a sting with new discovery
A paper authored by 44 of our scientists was published in the scientific journal Nature, revealing a potential new class of immunotherapy drugs to treat some cancers.
-
Innovation
On target for a new era of drug discovery?
Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.
-
Innovation
COPD is more than a lung disease
Ruth Tal-Singer works in respiratory research and development. Here she shares her unique perspective on how the future of COPD treatment is changing, and how it's about treating more than just the lung.
-
How we do business
Evolving our graduated approach to intellectual property
In developing countries, millions of people have no access to even the most basic healthcare services, including safe and effective medicines.